Acadia Pharmaceuticals | ACAD - Przychody Ze Sprzedaży





Obroty Zmiana Data
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
ALKERMES USD 392.91M 8.41M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Cytokinetics USD 19.35M 1.59M 2026-03
Eisai JPY 205.43B 14.51B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Incyte USD 1.27B 240M 2026-03
J&J USD 25.31B 1.21B 2026-06
Moderna USD 389M 289M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Prothena USD 51.08M 51.06M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Vertex Pharmaceuticals USD 2.99B 200M 2026-03